NCT00868374 - Quetiapine Extended Release (XR) Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Disorder | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions

Major Depressive DisorderGeneralized Anxiety Disorder

Interventions

DRUG

Quetiapine XR

Days 1-14 - 50 mg/day; Days 14-21 - 100mg/day; Day 21-End of Study - 150mg/day

DRUG

Placebo

Days 1-14 - 50 mg/day; Days 14-21 - 100mg/day; Day 21-End of Study - 150mg/day

Trial Locations (1)

University Hospitals Cleveland Medical Center, Cleveland